Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
0.9454
-0.0446 (-4.51%)
At close: Feb 6, 2026, 4:00 PM EST
0.9643
+0.0189 (2.00%)
After-hours: Feb 6, 2026, 7:06 PM EST
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $8.57 million as of February 6, 2026. Its market cap has decreased by -42.35% in one year.
Market Cap
8.57M
Enterprise Value
9.75M
1-Year Change
-42.35%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $8.57M, a decrease of -85.37%. That is a compound annual growth rate of -36.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 8.57M | -15.59% |
| Dec 31, 2025 | 10.15M | -30.28% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
| Nov 5, 2021 | 58.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FONAR | 121.40M |
| Biodesix | 79.24M |
| Exagen | 76.15M |
| Precipio | 35.69M |
| Inotiv | 13.40M |
| Check-Cap | 11.08M |
| Advanced Biomed | 5.17M |
| ENDRA Life Sciences | 4.42M |